Cargando…
Site of Metastases as Prognostic Factors in Unselected Population of Stage IV Non-Small Cell Lung Cancer
BACKGROUND: Advanced stage non-small cell lung cancer (NSCLC) is a heterogenous disease, yet, with the exception of targeted therapies, most guidelines recommended uniform treatment irrespective of tumor burden or sites of metastases and this may explain, in part, the wide range of responses to same...
Autores principales: | Badawy, Ahmed Ashour, Khedr, Gehan, Omar, Abbas, Bae, Sejong, Arafat, Waleed, Grant, Stefan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
West Asia Organization for Cancer Prevention
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6165640/ https://www.ncbi.nlm.nih.gov/pubmed/30051671 http://dx.doi.org/10.22034/APJCP.2018.19.7.1907 |
Ejemplares similares
-
Survival rates and prognostic factors in right- and left-sided colon cancer stage I–IV: an unselected retrospective single-center trial
por: Degro, Claudius E., et al.
Publicado: (2021) -
Severe hyperlactatemia in unselected surgical patients: retrospective analysis of prognostic outcome factors
por: Spiegelberg, Julia, et al.
Publicado: (2022) -
Prognostic Value of Site-Specific Metastases and Surgery in De Novo Stage IV Triple-Negative Breast Cancer: A Population-Based Analysis
por: Gu, Yinfang, et al.
Publicado: (2020) -
Patients presenting with metastases: stage IV uveal melanoma, an international study
por: Garg, Gaurav, et al.
Publicado: (2022) -
Treatments for brain metastases from EGFR/ALK-negative/unselected NSCLC: A network meta-analysis
por: Zhang, Chengkai, et al.
Publicado: (2023)